Variation in clinical practice guidelines for use of palivizumab in preventing severe respiratory syncytial viral (RSV) disease in high-risk infants.
Pediatric pulmonology（2023）
摘要
Standardization of CPGs may improve clinical decision making around use of palivizumab in high-risk infants.
更多查看译文
关键词
Palivizumab,RSV,guideline,infants,prophylaxis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要